Correlation Between Abcellera Biologics and OS Therapies

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and OS Therapies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and OS Therapies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and OS Therapies Incorporated, you can compare the effects of market volatilities on Abcellera Biologics and OS Therapies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of OS Therapies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and OS Therapies.

Diversification Opportunities for Abcellera Biologics and OS Therapies

-0.41

Correlation Coefficient

Abcellera Biologics  OS Therapies

Very good diversification

The 3 months correlation between Abcellera and OSTX is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and OS Therapies Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OS Therapies and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with OS Therapies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OS Therapies has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and OS Therapies go up and down completely randomly.

Pair Corralation between Abcellera Biologics and OS Therapies

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.22 times less return on investment than OS Therapies. But when comparing it to its historical volatility, Abcellera Biologics is 2.38 times less risky than OS Therapies. It trades about 0.03 of its potential returns per unit of risk. OS Therapies Incorporated is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  352.00  in OS Therapies Incorporated on September 18, 2024 and sell it today you would lose (50.00) from holding OS Therapies Incorporated or give up 14.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  OS Therapies Incorporated

Abcellera Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

OS Therapies

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in OS Therapies Incorporated are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, OS Therapies may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Abcellera Biologics and OS Therapies

The main advantage of trading using opposite Abcellera Biologics and OS Therapies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, OS Therapies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OS Therapies will offset losses from the drop in OS Therapies' long position.

The idea behind Abcellera Biologics and OS Therapies Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.